MENU
WDNA
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

WDNA stock forecast, quote, news & analysis

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”)... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for WDNA with price predictions
Nov 18, 2026

WDNA sees MACD Histogram just turned negative

WDNA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 05, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 35 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WDNA as a result. In 60 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

WDNA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for WDNA crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in 213 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

WDNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 200 of 239 cases where WDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), ZOETIS (NYSE:ZTS), Illumina (NASDAQ:ILMN).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution Fund (WDNA) ETF is 54.55B. The market cap for tickers in the group ranges from 261.81M to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is RCKT at 261.81M.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution Fund (WDNA) ETF was -8%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was 23%. CGON experienced the highest price growth at 10%, while NPCE experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution Fund (WDNA) ETF was 21%. For the same stocks of the ETF, the average monthly volume growth was 20% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 50
Price Growth Rating: 50
SMR Rating: 80
Profit Risk Rating: 81
Seasonality Score: 15 (-100 ... +100)
WDNA sees MACD Histogram just turned negative